0001209191-23-056288.txt : 20231121
0001209191-23-056288.hdr.sgml : 20231121
20231121164036
ACCESSION NUMBER: 0001209191-23-056288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Henderson Molly
CENTRAL INDEX KEY: 0001363812
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 231428795
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-20
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001363812
Henderson Molly
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM
NJ
07932
0
1
0
0
CFO and CBO
0
Common Stock
2023-11-20
4
S
0
2127
7.2415
D
103061
D
Common Stock
1134.27
I
By 401(k)
Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $7.24 and $7.2893. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
2023-11-21